Glucose-Dependent Insulinotropic Polypeptide Plasma Level Influences the Effect of n-3 PUFA Supplementation

Glucose-Dependent Insulinotropic Polypeptide Plasma Level Influences the Effect of n-3 PUFA Supplementation

Elevated glucose-dependent insulinotropic peptide (GIP) levels in obesity may predict the metabolic benefits of n-3 PUFA supplementation. This placebo-controlled trial aimed to analyze fasting and postprandial GIP response to 3-month n-3 PUFA supplementation (1.8 g/d; DHA:EPA, 5:1) along with calori...

Full description

Bibliographic Details
Main Authors: Joanna Goralska, Urszula Razny, Philip C. Calder, Anna Gruca, Caroline E. Childs, Piotr Zabielski, Aldona Dembinska-Kiec, Maciej Banach, Bogdan Solnica, Malgorzata Malczewska-Malec
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Diagnostics
Subjects:
glucose-dependent insulinotropic polypeptide
GIP
incretin
gut hormone
n-3 PUFA
DHA
Online Access:https://www.mdpi.com/2075-4418/12/8/1984

Internet

https://www.mdpi.com/2075-4418/12/8/1984

Similar Items